| Name | Title | Contact Details |
|---|
Han Auto Trend is a Monterey Park, CA-based company in the Business Services sector.
Tmc Pacific Modelworks is a Scottsdale, AZ-based company in the Business Services sector.
Clear Edge Marketing is a Chicago, IL-based company in the Business Services sector.
Seneca helps 10,000,000+ students to learn better. Our homework & revision platform applies cognitive neuroscience to make learning more efficient and enjoyable. We offer 800+ free courses covering all subjects and exam boards. In a Randomised Control Trial with 1,120 participants, weve proven that students using Seneca obtained test scores 2x higher than their peers using other revision resources. We want every student to have an equal opportunity for the best education and Seneca makes that possible. Senecas algorithms are adaptive and personalize students education to their abilities, prior knowledge and performance. Our algorithms are based on students knowledge and performance, as well as principles such as the ‘Forgetting Curve to deliver an optimal learning experience. Seneca uses spaced repetition, active retrieval, interleaving, multimodal representations and visual memory cues to increase students retention of information.
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.